Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,507 JPY | +2.17% |
|
+0.74% | -13.34% |
2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
ETFs positioned on Fuji Pharma Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 14 M€ | +17.18% | ||
0.00% | 17 M€ | +18.02% | - | |
0.00% | 138,841 M€ | +23.06% | ||
0.00% | 19,753 M€ | +22.02% | - |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.34% | 228M | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B | |
-2.57% | 159B |
- Stock Market
- Equities
- 4554 Stock
- ETFs Fuji Pharma Co., Ltd.